Depressive Disorder, Major Clinical Trials

30 recruiting

Frequently Asked Questions

Common questions about Depressive Disorder, Major clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 33 trials

Recruiting
Not Applicable

Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation

Depressive Disorder, Major
Charite University, Berlin, Germany165 enrolled1 locationNCT05909267
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Depressive Disorder, Major
Janssen Research & Development, LLC258 enrolled2 locationsNCT07227454
Recruiting
Phase 3

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Depressive Disorder, Major
Janssen Research & Development, LLC752 enrolled200 locationsNCT06559306
Recruiting

A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)

Depressive Disorder, Major
Janssen Research & Development, LLC80 enrolled14 locationsNCT07258485
Recruiting
Phase 2

A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

Depressive Disorder, Major
Janssen Research & Development, LLC124 enrolled43 locationsNCT06785012
Recruiting
Not Applicable

Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia

Depressive Disorder, Major
GrayMatters Health Ltd.170 enrolled3 locationsNCT06982820
Recruiting
Not Applicable

Biomarkers of Depression and Treatment Response

Depressive Disorder, Major
University of California, San Francisco50 enrolled1 locationNCT04581902
Recruiting
Not Applicable

Dosing rTMS for Depression Post-SCI

DepressionSpinal Cord InjuriesDepressive Disorder, Major
VA Office of Research and Development24 enrolled1 locationNCT05553353
Recruiting
Phase 2

Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation

Anxiety DisorderDepressive Disorder, Major
Mclean Hospital112 enrolled1 locationNCT05232032
Recruiting
Phase 2

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

DepressionDepressive DisorderMolecular Mechanisms of Pharmacological Action+10 more
National Institute of Mental Health (NIMH)50 enrolled1 locationNCT06511908
Recruiting
Not Applicable

Comparing the Efficacy of fMRI-Guided vs. Standard iTBS in Treating Depression

DepressionDepressive Disorder, MajorDepressive Episode
The Royal Ottawa Mental Health Centre210 enrolled1 locationNCT06152705
Recruiting
Not Applicable

Improving Treatment for Depression in General Practice Using a Step-by-Step Care Plan.

DepressionDepressive DisorderDepression - Major Depressive Disorder+4 more
Aalborg University Hospital171 enrolled1 locationNCT07263321
Recruiting
Not Applicable

Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness

SchizophreniaBipolar DisorderDepressive Disorder, Major+1 more
VA Office of Research and Development20 enrolled1 locationNCT05491538
Recruiting
Phase 3

Treating Immuno-metabolic Depression With Anti-inflammatory Drugs

InflammationDepressive Disorder, Major
Amsterdam UMC, location VUmc140 enrolled1 locationNCT05415397
Recruiting

Prediction of Antidepressant Effects of Electroconvulsive Therapy

Depressive Disorder, Major
Medical University of Vienna30 enrolled1 locationNCT05630469
Recruiting
Not Applicable

The Motor Activity - Subjective Energy (MASE) Project

Depressive Disorder, Major
University of Bern180 enrolled1 locationNCT07059234
Recruiting
Not Applicable

Comparing the Efficacy of Accelerated vs. Standard fMRI-guided iTBS in Treating Adolescents Depression

DepressionDepressive Disorder, Major
The Royal Ottawa Mental Health Centre10 enrolled1 locationNCT06528938
Recruiting
Not Applicable

Exploring the Role of the Prefrontal Cortex in Decision-Making

Healthy VolunteerAgingDepressive Disorder, Major Depressive Disorder
University of Bern444 enrolled1 locationNCT07080489
Recruiting
Phase 4

Optimal Electrical Stimulus During Electroconvulsive Therapy

Depression BipolarDepressive Disorder, Major
Region Örebro County800 enrolled1 locationNCT04057378
Recruiting

Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression

Depressive; Disorder, Major, Single Episode, Major, With Psychotic SymptomsDepressive; Disorder, Major, Single Episode, Major (Without Psychotic Symptoms)Depressive Disorder, Major, Recurrent, With Psychotic Symptoms+4 more
Max-Planck-Institute of Psychiatry130 enrolled1 locationNCT06396312